According to vTv Therapeutics
's latest financial reports the company has a price-to-book ratio of 2.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | -1.26 | -113.65% |
2022-12-31 | 9.25 | 111.38% |
2021-12-31 | 4.38 | -88.22% |
2020-12-31 | 37.1 | -401.77% |
2019-12-31 | -12.3 | 117.83% |
2018-12-31 | -5.65 | -43.81% |
2017-12-31 | -10.1 | -300.35% |
2016-12-31 | 5.02 | 87.73% |
2015-12-31 | 2.67 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.7844 | -64.75% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 3.48 | 56.18% | ๐บ๐ธ USA |